Shares of bioAffinity Technologies, Inc. (BIAF) have dipped sharply since its second-quarter 2025 earnings release. The stock has lost 11% since the company reported results for the quarter ended June 30, 2025, compared with a 1.1% decline in the S&P 500 Index over the same period. Over the past month, bioAffinity shares have plunged 27.4%, while the S&P 500 gained 1.5%. BIAF's Earnings Snapshot For the second quarter of 2025, bioAffinity reported revenues of $1.3 million, a 47.1$2.4 million ...